Answers are grounded in this paper and cite their sources.
Combined with stable insulin doses, sotagliflozin 200 mg and 400 mg improved glycaemic control and weight in adults with T1D. Sotagliflozin 400 mg reduced PPG levels. UGE increased with all sotagliflozin doses. Rates of severe hypoglycaemia and DKA were low (NCT02459899).
No takes yet. Share an insight, caveat, or question.
Baker et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: